This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_THYROID_FOLLICULAR_EXALLC for full statistics.
Follicular adenocarcinoma of thyroid gland
C3_THYROID_FOLLICULAR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
222 |
4. Check minimum number of eventsNone |
222 |
5. Include endpointsNone |
222 |
6. Filter based on genotype QC (FinnGen only) |
222 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Follicular adenocarcinoma of thyroid gland
based on the number of shared cases.
Similar with more cases:
- Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of thyroid gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 222 | 139 | 83 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 50.91 | 47.22 | 57.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 204
- Matched controls
- 2040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
268.8
194
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
11335.3
228.0
175
*
104
Kela drug reimbursment
Thyroid insufficiency
69.1
129.0
156
91
H03AA01
ATC
levothyroxine sodium; systemic
90.0
118.9
193
332
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
142.3
104.3
105
15
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
250.3
80.7
78
5
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
275.8
74.7
72
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
509.5
72.5
68
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
28.9
69.2
98
63
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
126.1
59.9
62
7
BAA60
NOMESCO Finland
Total thyroidectomy
47.6
46.5
56
16
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
67.4
45.2
51
10
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
37.7
35
*
ZX114
NOMESCO Finland
Intramuscular
79.7
35.4
39
6
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
380.6
32.9
32
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
40.4
27.5
34
10
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
13.6
23.8
42
38
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.4
22.2
119
490
4CJ01
NOMESCO Finland
NA
245.2
22.0
22
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
245.2
22.0
22
*
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
20.1
19
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
220.5
19.9
20
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
196.3
17.8
18
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
17.1
14.8
23
15
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
14.9
14.6
24
18
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
36.9
13.7
17
5
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
12.6
12
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
16.3
11.5
18
12
Z51.88
ICD-10 Finland
Other specified medical care
12.2
11.3
20
18
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.5
10
*
WW200
NOMESCO Finland
Immunization
9.9
9.8
19
21
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
+∞
9.4
9
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
38.5
9.1
11
*
106
Kela drug reimbursment
Hypoparathyroidism
93.8
8.5
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
8.2
86
462
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
34.9
8.2
10
*
2506
FHL
Thyroidectomy
83.0
7.5
8
*
JN5SN
NOMESCO Finland
NA
83.0
7.5
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
31.2
7.2
9
*
WX402
NOMESCO Finland
General anaesthesia
2.8
6.7
44
180
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.8
6.5
14
19
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
72.0
6.5
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
11.5
6.4
11
10
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
6.3
6
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
9.0
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
163
6
974.83
193.49
9.4
6.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
54
37
18.96
62.67
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
29
29
11.35
26.17
1.8
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
130
545
4.34
26.11
8.6
4.0
ph
7.4
7.4
0.80
52
104
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
169
883
4.83
24.41
12.3
6.5
mmol/l
1.2
1.2
0.40
125
742
(4035726)
62
156
5.13
24.11
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
158
809
4.31
22.89
9.5
5.5
mmol/l
1.2
1.2
0.44
150
729
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
203
1359
6.77
18.14
12.4
3.9
pmol/l
17.9
14.9
29.37
193
1216
(3015377) Calcium [Moles/volume] in Serum or Plasma
125
615
3.36
17.73
4.1
3.3
mmol/l
2.3
2.4
3.98
114
537
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
49
130
4.55
17.49
2.6
3.9
ng/l
44.9
82.0
5.10
39
121
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
204
1645
3.96
8.21
16.9
4.7
mu/l
3.4
1.9
0.53
194
1493
(3002256) Pathology report gross observation
48
203
2.74
7.98
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
148
2.80
6.78
4.0
3.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
180
2.57
6.26
3.6
3.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
111
746
1.98
5.81
2.8
2.3
nmol/l
80.1
76.0
0.93
102
657
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
121
844
1.95
5.62
4.3
4.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
34
4.33
5.44
1.3
1.9
iu/l
3.2
4.3
—
5
11
(3024561) Albumin [Mass/volume] in Serum or Plasma
112
777
1.89
5.14
4.4
4.1
g/l
36.4
35.7
0.82
102
732
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
173
1413
2.02
4.53
9.7
6.9
u/l
75.8
77.2
0.29
163
1319
(3002179) Metamyelocytes/100 leukocytes in Blood
28
125
2.42
4.10
3.8
4.3
%
1.0
0.4
—
5
25
(3032080) INR in Blood by Coagulation assay
101
719
1.74
3.96
10.9
8.4
inr
1.3
1.2
0.15
44
232
(3025159) Blasts/100 leukocytes in Blood
28
129
2.34
3.83
3.6
4.5
%
0.4
0.0
—
5
35
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
116
2.41
3.82
1.2
1.2
iu/ml
57.1
168.7
1.59
11
45
(3021440) Promyelocytes/100 leukocytes in Blood
29
138
2.27
3.69
3.8
4.4
%
0.0
0.2
—
6
43
(3041096) Erythrocytes [Presence] in Urine by Automated
76
509
1.75
3.63
4.4
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
75
511
1.71
3.33
4.8
4.1
estimate
0.0
0.0
0.00
35
174
(40768804) Tissue Pathology biopsy report
97
715
1.63
3.15
2.6
2.1
—
—
—
0
0
(3013512) EKG study
76
527
1.67
3.13
3.6
4.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
29
148
2.10
3.12
3.8
4.3
%
0.5
0.9
—
6
47
(3013826) Glucose [Moles/volume] in Serum or Plasma
136
1098
1.62
2.99
4.4
4.4
mmol/l
6.3
6.7
1.71
125
1010
(40760888) Immunoglobulin light chains.free panel - Serum
11
35
3.25
2.97
3.2
5.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
80
569
1.63
2.96
2.6
2.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
106
808
1.60
2.95
12.9
9.8
e9/l
0.0
0.0
0.53
92
661
(3013290) Carbon dioxide [Partial pressure] in Blood
12
41
3.04
2.90
2.8
2.5
kpa
5.0
5.0
0.03
12
41
(3027315) Oxygen [Partial pressure] in Blood
12
41
3.04
2.90
2.8
2.5
kpa
9.1
8.9
0.15
12
41
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
53
2.75
2.85
2.6
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
57
376
1.69
2.80
2.4
3.0
mosm/kgh2o
511.3
552.9
0.97
46
318
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
1067
1.56
2.63
8.3
9.3
e9/l
3.9
4.1
0.42
111
931
(3000850) Epithelial cells [#/volume] in Urine
58
395
1.63
2.51
2.5
2.7
e6/l
3.3
4.4
0.70
49
351
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
94
721
1.53
2.42
4.8
4.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
120
970
1.52
2.41
7.0
5.7
umol/l
11.2
10.6
0.56
111
918
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
18
3.98
2.27
1.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
69
501
1.55
2.26
2.4
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
67
490
1.53
2.11
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
31
2.98
2.09
1.7
3.3
%
59.7
61.1
—
9
31
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
31
2.98
2.09
1.7
2.7
e9/l
3.8
4.9
—
9
31
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
671
1.46
1.95
2.6
3.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
33
2.80
1.95
1.0
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
33
2.80
1.95
1.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
16
3.82
1.95
1.0
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
86
672
1.46
1.94
2.9
4.0
e6/l
62.7
115.9
0.55
66
477
(3042631) Mycobacterium sp identified in Specimen
7
22
3.25
1.89
3.4
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
202
1876
1.85
1.89
19.9
13.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
196
1805
1.73
1.89
20.2
14.4
mg/l
18.3
22.2
1.11
150
1441
(3047181) Lactate [Moles/volume] in Blood
10
40
2.57
1.86
2.1
6.6
mmol/l
1.3
1.3
—
10
35
(3019550) Sodium [Moles/volume] in Serum or Plasma
199
1842
1.78
1.86
19.3
16.5
mmol/l
139.8
139.6
0.34
193
1785
(3023103) Potassium [Moles/volume] in Serum or Plasma
199
1844
1.76
1.82
19.9
16.6
mmol/l
3.9
4.0
0.85
191
1788
(3000494) Fungus identified in Specimen by Culture
11
228
0.46
1.81
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
73
568
1.42
1.64
2.6
3.4
e6/l
97.5
158.6
0.20
58
439
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
740
1.39
1.58
4.1
4.1
ng/l
21.2
39.3
2.13
60
521
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
430
1.44
1.51
2.3
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
65
505
1.41
1.46
4.2
3.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
22
2.77
1.44
1.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
22
2.77
1.44
2.2
1.8
%
89.9
90.3
—
6
22
(42870588) Differential panel, method unspecified - Blood
72
571
1.39
1.43
5.7
5.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
56
430
1.40
1.34
4.1
4.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
35
2.33
1.28
2.6
2.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
35
2.33
1.28
3.9
2.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
166
1516
1.38
1.26
20.6
17.7
%
13.7
13.7
0.12
161
1496
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
144
0.47
1.25
1.4
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
183
1700
1.44
1.24
19.2
13.3
ml/min/173m2
81.5
80.2
0.32
158
1398
(3044889) 12 lead EKG panel
138
1229
1.32
1.22
4.5
4.0
—
—
—
0
0
(3019225) pH of Specimen
24
158
1.58
1.21
11.5
4.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
57
1.98
1.19
4.1
2.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
33
0.00
1.17
0.0
1.1
—
2.8
—
0
16
(3023183) Ammonium ion [Moles/volume] in Plasma
0
33
0.00
1.17
0.0
4.2
—
39.4
—
0
28
(3020682) Albumin/Creatinine [Ratio] in Urine
41
535
0.71
1.14
5.7
4.0
mg/mmol
19.3
9.0
0.42
27
336
(3030467) Casts [#/volume] in Urine by Automated count
65
526
1.33
1.12
2.4
3.2
e6/l
0.3
0.3
0.05
51
397
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
90
1.71
1.07
2.9
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
106
923
1.28
1.05
4.6
3.9
estimate
0.0
0.0
0.00
37
178
(3009261) Glucose [Presence] in Urine by Test strip
107
933
1.28
1.05
4.6
4.0
estimate
0.0
0.0
0.00
35
168
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
106
0.46
1.04
4.8
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
50
393
1.35
1.04
1.8
1.8
pmol/l
420.6
452.8
0.33
39
329
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
190
1.48
1.03
1.5
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
18
116
1.60
1.00
7.0
3.3
ph
7.4
7.4
—
7
15
(3026389) Candida sp identified in Specimen by Organism specific culture
5
23
2.20
0.98
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
158
1.51
0.98
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
30
0.00
0.98
0.0
1.2
—
1.1
—
0
11
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
30
0.00
0.98
0.0
1.2
—
1.5
—
0
12
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
36
1.97
0.98
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
17
255
0.64
0.98
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
51
1.80
0.96
1.3
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
43
541
0.75
0.95
4.0
3.0
mmol/l
7.4
7.2
0.08
37
456
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
52
1.76
0.93
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
40
504
0.75
0.89
4.4
3.2
mg/l
1665.8
322.6
0.40
29
322
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
52
421
1.31
0.89
2.7
2.1
mg/l
4.2
3.2
0.86
46
367
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
213
0.63
0.86
4.0
4.8
%
31.1
32.9
—
7
136
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
31
1.96
0.85
1.2
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
0.8
—
0
12
(4306422)
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
26
0.00
0.79
0.0
1.7
—
12.8
—
0
18
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.0
—
10.7
—
0
17
(3026008) Bacteria identified in Urine by Culture
69
588
1.25
0.79
3.1
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
61
716
0.80
0.78
2.2
2.0
pmol/l
93.7
96.5
0.19
34
359
(3001019) Free T4 and TSH panel - Serum or Plasma
12
76
1.61
0.73
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.2
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
25
2.02
0.73
1.0
2.9
—
20.3
—
0
7
(3021601) Nitrite [Presence] in Urine by Test strip
103
924
1.21
0.72
5.7
5.4
estimate
0.0
0.0
0.00
35
172
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
28
1.80
0.66
2.2
1.3
—
—
—
0
0
(4010399)
8
128
0.61
0.66
1.3
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
135
1254
1.20
0.62
5.1
4.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
198
1912
1.33
0.61
12.5
10.1
u/l
23.9
25.0
0.65
191
1842
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
114
1.43
0.60
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(4268621)
0
21
0.00
0.60
0.0
2.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
111
0.62
0.60
1.4
1.3
—
47.0
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
113
0.61
0.60
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
12
172
0.68
0.59
3.0
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
36
435
0.79
0.59
4.1
3.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
90
811
1.18
0.57
5.6
5.5
%
0.7
0.7
0.18
81
752
(40768793) Breast Pathology biopsy report
8
55
1.47
0.56
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
161
1687
0.83
0.54
3.8
4.0
mmol/l
1.4
1.3
1.28
145
1549
(3007461) Platelets [#/volume] in Blood
205
1995
1.36
0.54
29.0
21.2
e9/l
253.3
248.6
0.49
200
1948
(3000764) Benzodiazepines [Presence] in Urine
9
62
1.47
0.54
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
63
1.45
0.53
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
64
1.42
0.52
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
64
1.42
0.52
1.4
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
205
1997
1.35
0.51
28.9
21.2
e12/l
4.5
4.5
0.42
200
1945
(3019069) Monocytes/100 leukocytes in Blood
93
847
1.17
0.51
6.4
5.8
%
8.5
8.5
0.05
84
792
(3016502) Oxygen saturation in Arterial blood
14
189
0.72
0.50
1.9
6.5
%
93.6
95.4
0.29
14
183
(3013115) Eosinophils [#/volume] in Blood
101
927
1.16
0.50
5.4
6.0
e9/l
0.2
0.2
0.85
83
827
(3001604) Monocytes [#/volume] in Blood
98
899
1.16
0.49
5.3
5.5
e9/l
0.5
0.6
0.82
82
777
(3007164) IgA [Mass/volume] in Serum or Plasma
32
383
0.81
0.49
1.8
1.4
g/l
2.5
2.5
0.03
24
219
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
46
1.54
0.49
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
54
472
1.19
0.48
2.9
2.8
umol/l
377.0
8451.3
2.67
44
397
(3004588) Protein electrophoresis panel - Serum or Plasma
16
120
1.36
0.47
4.8
2.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
92
842
1.16
0.47
5.9
5.5
%
2.4
2.8
1.27
83
781
(3013707) Erythrocyte sedimentation rate by Westergren method
144
1362
1.16
0.47
4.1
4.0
mm/h
12.5
12.1
0.09
131
1242
(3012544) pH of Venous blood
22
174
1.29
0.47
1.5
4.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
81
0.61
0.46
1.0
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
98
902
1.15
0.46
5.5
5.5
e9/l
0.0
0.0
0.34
81
783
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
230
1.25
0.45
8.1
7.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
30
249
1.24
0.44
2.8
2.4
%
24.6
21.7
0.32
23
220
(3014576) Chloride [Moles/volume] in Serum or Plasma
19
238
0.78
0.43
2.7
6.2
mmol/l
103.5
103.7
0.08
19
230
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
32
1.58
0.42
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
298
1.21
0.41
2.3
1.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
33
1.53
0.41
1.4
1.1
u/l
9.4
15.9
—
5
28
(3000991) Gas panel - Venous blood
11
149
0.72
0.41
2.0
7.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
15
0.00
0.41
0.0
5.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(4281824)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.0
—
1.9
—
0
7
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
14.9
—
802.0
—
0
17
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
21.4
—
1459.2
—
0
17
(3016879) Cocaine [Presence] in Urine
8
60
1.35
0.40
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
34
1.48
0.40
1.4
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
100
929
1.14
0.40
5.5
5.6
e9/l
1.7
2.0
1.09
85
830
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
99.3
—
0
18
(1617658) Protocol used for examination of sentinel lymph nodes
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
19
0.00
0.39
0.0
1.3
—
299.7
—
0
19
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
19
0.00
0.39
0.0
4.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
21
170
1.26
0.39
1.4
4.5
mmol/l
2.4
1.8
0.31
13
136
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
169
1748
0.86
0.38
4.3
4.4
mmol/l
1.4
1.5
0.83
152
1612
(4034850)
9
67
1.36
0.38
11.3
10.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
14
107
1.33
0.38
2.6
5.9
mmol/l
24.5
24.7
0.11
14
107
(3037756) Immunofixation for Serum or Plasma
5
37
1.36
0.37
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
12
157
0.75
0.37
1.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
41
1.48
0.36
1.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
80
0.62
0.36
1.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
73
1.39
0.35
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
87
0.68
0.33
1.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
165
0.77
0.33
1.2
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
128
1.27
0.33
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
64
586
1.13
0.32
2.3
2.3
u/l
103.2
55.3
0.55
53
546
(3002030) Lymphocytes/100 leukocytes in Blood
93
871
1.12
0.32
5.9
5.7
%
26.0
27.7
0.72
84
808
(36660697) Celiac disease serology panel - Serum
11
142
0.76
0.32
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
53
1.33
0.31
1.4
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
108
0.73
0.29
1.1
1.3
u/ml
314.8
378.9
—
8
102
(3025941) Bacteria identified in Stool by Culture
8
110
0.72
0.29
1.1
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
37
415
0.87
0.29
1.4
1.9
mg/l
1.0
1.3
0.48
31
322
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
31
351
0.86
0.27
3.2
3.6
ng/l
532.5
171.6
0.33
24
276
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
66
1.22
0.27
1.3
5.0
%
1.6
1.6
—
8
61
(3007930) Methemoglobin/Hemoglobin.total in Blood
8
66
1.22
0.27
1.3
5.0
%
1.0
0.9
—
8
61
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
107
1123
0.91
0.27
3.2
3.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
67
622
1.11
0.26
2.7
3.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
28
317
0.87
0.25
1.8
2.8
e6/l
2.1
1.2
0.44
16
183
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
410
0.88
0.25
1.2
1.2
u/ml
0.7
1.6
1.01
14
106
(3018010) Neutrophils/100 leukocytes in Blood
91
861
1.10
0.25
5.6
5.4
%
60.3
57.5
1.22
82
804
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
10
78
1.30
0.24
2.6
1.8
ug/l
0.3
4.4
—
10
70
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
172
1761
0.90
0.24
4.4
4.5
mmol/l
4.6
4.6
0.04
156
1632
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
162
1662
0.91
0.23
5.6
5.8
mmol/mol
39.6
40.0
0.25
145
1557
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
40
1.26
0.22
2.0
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.2
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
103
0.77
0.21
2.6
4.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3035880) pH of Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.6
—
234.5
—
0
10
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
16.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
0.9
—
0
10
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
714.6
—
0
10
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
292
0.88
0.21
1.8
3.1
e6/l
3.4
2.8
0.14
14
159
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
375
1.11
0.21
4.7
4.4
%
19.8
21.3
0.30
21
191
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
12
0.00
0.21
0.0
1.2
—
1.1
—
0
5
(3017569) Oxygen content in Arterial blood
0
13
0.00
0.21
0.0
6.6
—
—
—
0
0
(44813793)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
23
260
0.87
0.20
1.6
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
212
1.15
0.20
1.5
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
24
212
1.15
0.20
1.7
2.4
umol/l
4.8
6.9
1.29
18
185
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
22
193
1.16
0.20
3.7
4.4
ug/l
2.7
31.0
0.67
17
153
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
2.5
—
0
5
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
51
475
1.10
0.19
5.7
4.8
ug/l
2.8
2.7
0.07
45
426
(3003396) Base excess in Arterial blood by calculation
18
206
0.86
0.19
2.4
6.4
mmol/l
2.0
1.3
0.51
13
166
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
58
1.21
0.18
1.3
1.3
iu/l
21.7
20.2
—
7
51
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
4.6
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
165
1615
1.08
0.17
18.3
15.1
%
40.2
39.9
0.12
103
1173
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
63
1.11
0.17
1.3
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
204
0.87
0.17
2.7
2.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
70
0.71
0.17
1.2
2.6
mmol/l
3.7
3.9
—
5
62
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
73
1.10
0.16
6.9
2.0
—
—
—
0
0
(1002224) Polysomnography panel
9
81
1.12
0.15
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
177
1798
0.92
0.15
4.7
5.0
mmol/l
2.8
2.7
0.20
159
1654
(3019150) Specific gravity of Urine by Refractometry
45
423
1.08
0.14
5.5
4.0
kg/l
1.0
1.0
0.36
12
54
(3001122) Ferritin [Mass/volume] in Serum or Plasma
81
779
1.06
0.14
3.3
2.7
ug/l
102.4
104.6
0.05
72
707
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
317
1.09
0.13
1.8
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
278
1.09
0.12
3.9
2.8
ug/l
0.9
0.8
0.22
19
189
(3022313) Gas panel - Capillary blood
10
85
1.18
0.12
9.7
3.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
309
1.08
0.11
1.2
1.3
u/ml
40.3
13.1
0.53
12
125
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
117
1197
0.95
0.11
3.2
2.9
u/l
42.2
43.6
0.14
99
1127
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
115
1.14
0.11
1.5
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
48
458
1.06
0.10
5.8
6.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
288
0.93
0.09
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
55
1.09
0.09
1.2
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
33
348
0.94
0.08
2.3
1.7
nmol/l
1406.5
1222.3
0.41
22
266
(1761482) Bacteria [#/volume] in Urine by Culture
5
61
0.82
0.08
2.4
5.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
64
1.10
0.08
2.4
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
327
0.94
0.08
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
68
1.03
0.08
5.4
1.9
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
72
0.83
0.07
2.5
3.1
u/ml
4.2
2024.7
—
6
65
(3045414) Leukocytes [Presence] in Urine
6
74
0.81
0.07
1.0
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
80
0.87
0.07
1.9
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
216
1.07
0.07
1.4
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
102
0.88
0.06
2.0
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
20
213
0.93
0.06
1.7
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
172
0.92
0.06
1.6
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
58
564
1.04
0.06
3.2
3.3
ng/l
758.7
1392.0
2.60
50
485
(3019060) Gas panel - Arterial blood
13
120
1.09
0.05
1.7
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
22
212
1.04
0.02
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
93
1.08
0.02
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
11
117
0.94
0.02
2.4
6.0
mmol/l
24.3
24.9
0.42
11
110
(3048689) Calprotectin [Mass/mass] in Stool
23
237
0.97
0.01
1.5
1.9
ug/g
127.7
119.4
0.04
17
179
(3005719) IgG [Mass/volume] in Serum or Plasma
14
134
1.05
0.00
3.8
2.3
g/l
9.6
10.0
0.21
14
122
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
156
0.96
0.00
2.8
3.1
ml/min/173m2
62.7
65.8
—
9
70
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
256
0.97
0.00
1.4
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
128
1.02
0.00
3.8
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
181
0.99
0.00
2.2
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
189
1.01
0.00
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
175
1746
1.01
0.00
4.5
4.6
mmol/l
5.9
6.0
0.17
157
1603
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
48
484
0.99
0.00
2.0
1.7
mmol/l
1.5
1.4
0.30
36
407
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
12
116
1.04
0.00
2.5
3.1
ng/l
337.8
226.3
0.18
12
105
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
33
328
1.01
0.00
1.2
1.3
iu/ml
21.2
34.1
0.97
12
110
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
125
0.96
0.00
2.0
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
27
272
0.99
0.00
1.8
2.2
s
29.2
30.0
0.37
27
262
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
69.1
—
0
7
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
57.1
—
0
7
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
78
0.89
0.00
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
30.7
—
0
9
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
1.2
1.6
g/l
0.2
0.2
—
6
60
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
64
0.94
0.00
7.2
2.2
g/l
0.4
0.9
—
6
58
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.0
—
4.0
—
0
6
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
99
0.91
0.00
1.3
3.1
%
0.9
1.2
—
9
99
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
64
0.94
0.00
1.8
2.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
8
80
1.00
0.00
2.1
3.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
81
0.99
0.00
2.5
7.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
32.3
—
0
9
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
62
0.97
0.00
7.2
2.0
g/l
40.4
38.1
—
6
54
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
61
0.98
0.00
1.2
1.6
g/l
1.1
1.1
—
6
61
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.4
miu/ml
260.2
283.5
—
5
22
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
56
0.89
0.00
1.2
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_THYROID_FOLLICULAR – Follicular adenocarcinoma of thyroid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).